To explore potential mechanisms underlying PARP inhibitor sensitivity in pediatric solid tumors, we examined biological pathways and genes correlated with talazoparib sensitivity in the pediatric cancer cell lines included in the GDSC2 database [25] . Here, PARP1 is linked to cancer.